Lyka Labs Share Price

Lyka Labs Share Price

NSE: LYKALABS
|
Pharmaceuticals
|
S Cap
₹ 86.70
+₹1.70 (2.00%)
1D
Last updated 22 Sep, 2026, 15:14 IST

Lyka Labs Share Price Today

As of 23 Sep 2026, Lyka Labs share price is ₹86.70. The stock opened at ₹86.70, compared to its previous close of ₹85.00. During today's trading session, Lyka Labs share price moved in the range of ₹86.70 to ₹86.70, with an average price of ₹86.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹44.10 and a high of ₹100.94. On the performance front, Lyka Labs share price has increased by 57.78% over the last six months and is down 12.98% on a year-on-year basis.

₹86.70
2.00% up today
₹86.70
1D LOW
1D HIGH

Lyka Labs Returns Calculator

Circuit
L
H
₹84.97
₹88.43
52-week
L
H
₹44.10
₹100.94

About Lyka Labs

Lyka Labs Share Price
ISIN
INE933A01014
Sector Market Cap
₹ 307.51 Cr

Lyka Labs Limited is an India-based pharmaceutical company engaged in the development, manufacture and marketing of quality finished dosages. The Company manufactures pharmaceutical products such as Dry Powder, Liquid, Lyophilized Injections and External Preparations for several International Markets and the Domestic Market. The Company’s R&D is engaged in the development of new formulations and has developed several products in the categories, such as Injectables: Lyophilized Injection, Liquid Injections & Dry Powder Injections, and Topical Preparation: Ointment /Creams and Lotions. It offers formulations, such as emollient, anti-aging, cleansing lotion, hair care products, anti-dandruff shampoo, sunscreen, anti-acne, antioxidant tablets, antioxidants combination, proton pump inhibitor, antifungal, anti-malarial, antibacterial, corticosteroid hormones and cephalosporins. The Company's subsidiaries include Lyka BDR International Limited and Lyka Exports Limited.

Lyka Labs Financial Highlights

  • Revenue: Lyka Labs reported revenue of ₹131.94 crore in FY26 vs ₹140.73 crore in FY25. It showed a decrease of 6.25% on a yearly basis.
  • Operating Profit: Lyka Labs reported an operating loss of ₹11.78 crore in FY26 vs ₹11.12 crore in FY25. It showed a decrease of 205.94% on a year-on-year basis.
  • Net Profit: Lyka Labs reported a net loss of ₹10.44 crore in FY26 vs ₹7.93 crore in FY25. It showed a decrease of 231.65% on a yearly basis.

Lyka Labs Quarterly Result Highlights

  • Lyka Labs reported revenue of ₹42.73 crore in Jun 2026, compared with ₹28.64 crore in Mar 2026, representing an increase of 49.20% on a quarter-on-quarter (QoQ) basis.
  • Lyka Labs reported an operating profit of ₹1.95 crore in Jun 2026, compared with ₹8.59 crore in Mar 2026, representing an increase of 122.70% on a quarter-on-quarter (QoQ) basis.
  • Lyka Labs reported a profit of ₹2.05 crore in Jun 2026, compared with ₹8.07 crore in Mar 2026, reflecting an increase of 125.40% on a QoQ basis.
  • The earnings per share (EPS) of Lyka Labs stood at ₹2.81 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
58.45%
FII
0.17%
Other DII
0.65%
Retail and other
40.72%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.18%
Dec 20250.17%
Mar 20260.29%
Jun 20260.17%
Mkt Cap Cr
307.51
P/E
-33.35
P/B
3.38
ROE
-10.86%
D/E
0.56
ROCE
-6.04%
Div. Yield
0.00%
EPS(TTM)
-8.93
Turnover
0.79
EV/EBITDA
724.10
Net Margin
-7.68%
Op. Margin
1.29%
ROA
-5.37%
Quick Ratio
0.88
Curr. Ratio
2.19
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Lyka Labs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Lyka Labs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Lyka Labs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,860.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Lyka Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹128.44₹138.50₹111.19₹93.07
Other Income₹3.50₹2.23₹1.45₹3.40
Total Revenue₹131.94₹140.73₹112.65₹96.47
Total Expenses₹143.72₹129.60₹113.17₹102.25
Profit Before Tax-₹11.78₹11.12-₹0.93-₹13.17
Tax-₹1.34₹3.19₹1.69-₹0.02
Profit After Tax-₹10.44₹7.93-₹2.62-₹13.15
EPS - Basic-₹2.81₹2.22-₹0.79-₹4.63
EPS - Diluted-₹2.81₹2.22-₹0.79-₹4.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹11.78₹11.12-₹0.93-₹13.17
Income before WC changes₹8.05₹19.59₹17.09₹18.61
Change in Assets-₹3.07-₹17.36-₹14.31₹1.70
Change in Liabilities₹0.57₹2.71₹0.51-₹11.56
Change in WC-₹2.50-₹14.65-₹13.80-₹9.86
Cash flow from Operations₹5.24₹1.90₹1.77₹8.95
Cash flow from Investing-₹9.41-₹11.80-₹9.49₹7.35
Cash flow from Financing₹4.19₹5.29₹1.95-₹21.64
Total Cash Flow₹0.02-₹4.60-₹5.76-₹5.34
Cash (Start of the year)₹1.34₹5.95₹11.71₹17.05
Cash (End of the year)₹1.36₹1.34₹5.95₹11.71

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹111.26₹108.77₹106.07₹107.32
Current Assets₹63.28₹67.43₹50.65₹44.20
Total Assets₹174.54₹176.20₹156.72₹151.52
Current Liabilities₹53.90₹46.63₹37.64₹32.60
Net Current Asset₹9.38₹20.80₹13.01₹11.61
Non-Current Liabilities₹29.81₹25.99₹50.82₹73.25
Equity Capital₹90.83₹103.58₹68.27₹45.67
Total Equity & Liabilities₹174.54₹176.20₹156.72₹151.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹120.91₹134.70₹106.40₹80.59
Other Income₹3.97₹2.76₹1.65₹3.45
Total Revenue₹124.88₹137.46₹108.04₹84.04
Total Expenses₹135.10₹126.36₹108.92₹90.08
Profit Before Tax-₹33.24₹11.10-₹0.93-₹13.21
Tax-₹0.95₹3.18₹1.34₹0.08
Profit After Tax-₹32.29₹7.92-₹2.27-₹13.29
EPS - Basic-₹9.05₹2.19-₹0.72-₹4.65
EPS - Diluted-₹9.05₹2.19-₹0.72-₹4.65

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹33.24₹11.10-₹0.93-₹13.21
Income before WC changes₹8.34₹19.10₹15.72₹18.10
Change in Assets-₹4.80-₹20.25-₹12.62-₹2.61
Change in Liabilities₹2.02₹2.57₹1.45-₹8.20
Change in WC-₹2.78-₹17.68-₹11.16-₹10.81
Cash flow from Operations₹5.09-₹1.62₹3.09₹6.87
Cash flow from Investing-₹9.42-₹11.22-₹8.61₹6.77
Cash flow from Financing₹4.19₹8.25₹2.71-₹20.33
Total Cash Flow-₹0.14-₹4.59-₹2.81-₹6.69
Cash (Start of the year)₹1.33₹5.91₹8.70₹15.38
Cash (End of the year)₹1.19₹1.33₹5.89₹8.70

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹110.29₹122.53₹136.15₹136.56
Current Assets₹60.45₹70.15₹49.86₹42.30
Total Assets₹170.75₹192.68₹186.02₹178.86
Current Liabilities₹53.50₹45.06₹35.91₹29.97
Net Current Asset₹6.95₹25.09₹13.95₹12.33
Non-Current Liabilities₹30.25₹26.01₹50.78₹72.46
Equity Capital₹87.00₹121.60₹99.33₹76.43
Total Equity & Liabilities₹170.75₹192.68₹186.02₹178.86
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
3
Neutral
3
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
72.69
Bullish
ATR (14)
1.75
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
75.18
Neutral
ADX(9)
41.94
Bearish
UO(9)
69.5
Neutral
ROC(12)
12.85
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
83.37
84.25
10D
82.99
82.58
20D
79.29
79.68
50D
71.96
74.42
100D
68.63
70.86
Volume trend — traded volume by day
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Lyka Labs Share Price
Lyka Labs
Pharmaceuticals
Add Stock
Add Another

Lyka Labs Share Price FAQs

Lyka Labs share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837